{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:22:52Z","timestamp":1790230972431,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.prostaglandins.2008.08.002","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T20:34:27Z","timestamp":1220474067000},"page":"54-61","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of endothelial thromboxane receptors in rabbit aorta"],"prefix":"10.1016","volume":"87","author":[{"given":"Sandra L.","family":"Pfister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2008.08.002_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0090-6980(99)00062-3","article-title":"Thromboxane A2 receptors: where have you gone?","volume":"60","author":"Halushka","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cellsig.2003.10.008","article-title":"Cell signalling through thromboxane A2 receptors","volume":"16","author":"Huang","year":"2004","journal-title":"Cell Signal"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib3","first-page":"411","article-title":"Thromboxane biosynthesis and metabolism in cardiovascular and renal disease","volume":"6","author":"Patrono","year":"1993","journal-title":"J Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib4","first-page":"S53","article-title":"Thromboxane as diagnostic tool and therapeutic target in cardiovascular disease","volume":"5","author":"Lorenz","year":"1992","journal-title":"Eicosanoids"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2005.10.001","article-title":"Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis","volume":"26","author":"Dogn\u00e9","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.RES.72.5.958","article-title":"Identification of functional PGH2\/TXA2 receptors on human endothelial cells","volume":"72","author":"Kent","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0006-291X(89)80216-5","article-title":"Endothelial thromboxane receptors: biochemical characterization and functional implications","volume":"158","author":"Sung","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib8","doi-asserted-by":"crossref","first-page":"35562","DOI":"10.1074\/jbc.274.50.35562","article-title":"Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A2","volume":"274","author":"Ashton","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(92)90705-N","article-title":"Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells","volume":"43","author":"Hunt","year":"1992","journal-title":"Biochem Pharm"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000138300.41642.15","article-title":"Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration","volume":"95","author":"Ashton","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.RES.87.9.739","article-title":"Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2)","volume":"87","author":"Gao","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0022-3565(24)36684-4","article-title":"The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha","volume":"281","author":"Kinsella","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI118518","article-title":"Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation","volume":"97","author":"Hirata","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib14","first-page":"4574","article-title":"Thromboxane A2 is a mediator of cyclooxygenase-2 dependent endothelial migration and angiogenesis","volume":"59","author":"Daniel","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","article-title":"Thromboxane A2 regulation of endothelial cell migration, angiogenesis and tumor metastasis","volume":"267","author":"Nie","year":"2000","journal-title":"Biochem BioPhys Res Commun"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib16","first-page":"H2320","article-title":"Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic","volume":"266","author":"Buzzard","year":"1994","journal-title":"Am J Physiol"},{"issue":"part 2","key":"10.1016\/j.prostaglandins.2008.08.002_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.HYP.29.1.303","article-title":"Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits","volume":"29","author":"Pfister","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.atherosclerosis.2006.02.004","article-title":"Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits","author":"Pfister","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib19","first-page":"H1021","article-title":"Vasorelaxation by an endothelium-derived metabolite of arachidonic acid","volume":"270","author":"Pfister","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib20","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1083\/jcb.99.6.2034","article-title":"Identification and isolation endothelial cells based on their increased uptake of acetylated-low density lipoprotein","volume":"99","author":"Voyta","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0076-6879(87)41080-X","article-title":"Measurement of prostaglandin by radioimmunoassay","volume":"141","author":"Campbell","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/0006-2952(93)90018-R","article-title":"Anti-peptide antibodies against the human platelet thromboxane A2\/prostaglandin H2 receptor. Production, purification and characterization","volume":"45","author":"Borg","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/01.RES.67.6.1562","article-title":"Characterization of the vascular thromboxane A2\/prostaglandin endoperoxide receptor in rabbit aorta","volume":"67","author":"Sessa","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib24","first-page":"H887","article-title":"Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets","volume":"267","author":"Matsuda","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.69.3.638","article-title":"Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells","volume":"69","author":"Matsuda","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib26","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.febslet.2007.07.011","article-title":"Peroxiredoxin-4 interacts with and regulates the thromboxane A(2) receptor","volume":"581","author":"Gigu\u00e8re","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.prostaglandins.2006.12.001","article-title":"Low expression of cell-surface thromboxane A2 receptor beta-isoform through the negative regulation of its membrane traffic by proteasomes","volume":"83","author":"Sasaki","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib28","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1111\/j.1742-4658.2005.04890.x","article-title":"15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells","volume":"272","author":"Coyle","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","article-title":"Cloning and expression of cDNA for a human thromboxane A2 receptor","volume":"349","author":"Hirata","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib30","doi-asserted-by":"crossref","first-page":"19256","DOI":"10.1016\/S0021-9258(17)32161-0","article-title":"Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor","volume":"269","author":"Raychowdhury","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib31","doi-asserted-by":"crossref","first-page":"25253","DOI":"10.1016\/S0021-9258(19)74595-5","article-title":"Characterization and chromosomal mapping of the human thromboxane A2 receptor gene","volume":"268","author":"Nusing","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0167-4889(99)00068-3","article-title":"Coupling of thromboxane A2 receptor isoforms to Galpha13: effects on ligand binding and signaling","volume":"1450","author":"Becker","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib33","doi-asserted-by":"crossref","first-page":"20412","DOI":"10.1074\/jbc.M907881199","article-title":"The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization","volume":"275","author":"Walsh","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib34","doi-asserted-by":"crossref","first-page":"29914","DOI":"10.1016\/S0021-9258(18)43968-3","article-title":"Phosphorylation and regulated expression of the human thromboxane A2 receptor","volume":"269","author":"Kinsella","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib35","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1074\/jbc.274.5.2645","article-title":"Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets","volume":"274","author":"Habib","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib36","doi-asserted-by":"crossref","first-page":"12774","DOI":"10.1074\/jbc.274.18.12774","article-title":"Differential signaling by the thromboxane receptor isoforms via novel GTP-binding protein, Gh","volume":"274","author":"Vezza","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0167-4889(00)00031-8","article-title":"Investigation of the role of the carboxyl-terminal tails of the \u03b1 and \u03b2 isoforms of the human thromboxane A2 receptor (TP) in mediating receptor:effector coupling","volume":"1496","author":"Walsh","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib38","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1074\/jbc.274.13.8941","article-title":"Internalization of the TXA2 receptor \u03b1 and \u03b2 isoforms","volume":"274","author":"Parent","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0304-4165(98)00109-3","article-title":"Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms","volume":"1425","author":"Miggin","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejphar.2005.10.060","article-title":"Histamine-induced vasodilation and vasoconstriction in the mesenteric resistance artery of the rat","volume":"529","author":"Jin","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-201x.2000.00660.x","article-title":"Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor","volume":"168","author":"Carey","year":"2000","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vph.2005.01.005","article-title":"Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s)","volume":"42","author":"Batenburg","year":"2005","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.ATV.0000012283.15789.67","article-title":"Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models","volume":"22","author":"Vincent","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.prostaglandins.2008.08.002_bib45","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cellsig.2008.04.006","article-title":"Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide","volume":"20","author":"Wikstr\u00f6m","year":"2008","journal-title":"Cell Signal"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882308000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882308000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:29:28Z","timestamp":1738355368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882308000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":45,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1098882308000592"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2008.08.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}